Weiss Multi-Strategy Advisers’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-222,998	Closed	-$4.16M	–	832
2022 Q1	$4.16M	Sell	222,998 -35,000	-14%	-$630K	0.1%	293
2021 Q4	$5.52M	Buy	+257,998	New	+$5.08M	0.12%	223

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Weiss Multi-Strategy Advisers's OCDX Position: Q2 2022 in Review

Weiss Multi-Strategy Advisers sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 222,998 shares — an estimated $4.16M sold.

Weiss Multi-Strategy Advisers first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $5.52M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Weiss Multi-Strategy Advisers reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 222,998 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $4.16M.
Weiss Multi-Strategy Advisers first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
Weiss Multi-Strategy Advisers's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $5.52M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.